General Information
BounceWatch is an independent company data service, not affiliated with Amplo Biotechnology. To contact Amplo Biotechnology, visit amplobiotechnology.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Amplo Biotechnology compare?
A PDF of Amplo Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Amplo Biotechnology soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Amplo Biotechnology on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Amplo Biotechnology
Business keywords: AAV therapies, neuromuscular junction diseases, congenital myasthenic syndromes, rare diseases, paralysis treatment, breathing difficulties, swallowing difficulties, genetic diseases, medical research, University of Tokyo, Professor Yuji Yamanashi, Institute of Medical Science, rare disease treatments, innovative medical solutions
Funding Rounds & Investors (3)
View AllAmplo Biotechnology Alternatives & Competitors
View All AlternativesDriving gene therapy breakthroughs to develop transformative AAV treatments for patients with ciliop...
The Liver Disease Company
Advancing science with curative potential for both cardiovascular and APOE4 associated Alzheimer's d...
FAQ About Amplo Biotechnology
Source: BounceWatch company record for Amplo Biotechnology, https://bouncewatch.com/company/amplo-biotechnology, updated 14 January 2025. When citing, please name BounceWatch and link this page.